Table 5 Contrast use, CAD extent and PCI procedures
| Â | Men (N = 346) | Women (N = 133) | p Value |
|---|---|---|---|
Contrast agents | Â | Â | |
Ioxaglic acid (ml) | 250 (200-340) | 211 (180-260) | < 0.02 |
Iodixanol (ml) | 220 (171-300) | 200 (160-300) | NS |
Iomeprol (ml) | 215 (134-334) | 226 (219-350) | NS |
CAD extent | Â | Â | |
1-vessel disease (%) | 29 | 34 | NS |
2-vessel diseases (%) | 36 | 34 | Â |
3-vessel diseases (%) | 35 | 32 | Â |
PCI procedure | Â | Â | |
Time interval to PCI (days) | 1 (1-4) | 2 (1-4) | NS |
BMS (%) | 51 | 61 | 0.052 |
DES (%) | 40 | 32 | NS |
Balloon angioplasty (%) | 9 | 14 | NS |
Thrombus aspiration (%) | 1 | 0 | NS |
Use of closure devices (%) | 83 | 81.5 | NS |
Failure (%) | 5 | 8 | NS |
GPIIb/IIIa antagonists (%) | 22 | 20 | NS |